Journey Medical Corporation Common Stock (DERM) Stock Price

DERMStock

$7.47+2.75%52W

Market Cap$210.84M

P/E—

PEG Ratio—

Div yield—

Beta1.09

DERM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-26.07%

Price vs S&P 500 (4W)13.91%

VGM Score50.66

Book Value / Share (Quarterly)$1.13

P/TBV (Annual)49.26x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-5.66%

Cash Flow / Share (Quarterly)$-0.25

Price vs S&P 500 (YTD)-15.93%

Gross Margin (TTM)65.44%

Net Profit Margin (TTM)-14.82%

EPS (TTM)$-0.38

10-Day Avg Trading Volume0.18M

EPS Excl Extra (TTM)$-0.38

Revenue Growth (5Y)6.79%

EPS (Annual)$-0.47

ROI (Annual)-20.01%

Gross Margin (Annual)66.17%

Net Profit Margin (5Y Avg)-31.88%

Cash / Share (Quarterly)$1.00

Revenue Growth QoQ (YoY)21.48%

ROA (Last FY)-12.08%

Revenue Growth TTM (YoY)15.00%

EBITD / Share (TTM)$-0.08

ROE (5Y Avg)-81.41%

Operating Margin (TTM)-9.80%

Cash Flow / Share (Annual)$-0.46

P/B Ratio5.94x

P/B Ratio (Quarterly)3.24x

Net Income / Employee (Annual)$-197,100

EV / Revenue (TTM)2.80x

Net Interest Coverage (TTM)-2.55x

ROA (TTM)-10.88%

EV / EBITDA (TTM)85.34x

EPS Incl Extra (Annual)$-0.47

Current Ratio (Annual)1.79x

Quick Ratio (Quarterly)1.38x

3-Month Avg Trading Volume0.25M

52-Week Price Return2.75%

Revenue / Employee (TTM)$1,115,200

Tangible BV / Share (Quarterly)$0.16

P/S Ratio (Annual)2.96x

Asset Turnover (Annual)0.65x

52-Week High$9.55

Operating Margin (5Y Avg)-26.16%

EPS Excl Extra (Annual)$-0.47

CapEx CAGR (5Y)44.27%

26-Week Price Return-14.14%

Quick Ratio (Annual)1.44x

13-Week Price Return20.48%

Total Debt / Equity (Annual)0.79x

Current Ratio (Quarterly)1.72x

Enterprise Value$181.26M

Revenue / Share Growth (5Y)-1.39%

Asset Turnover (TTM)0.73x

Revenue / Employee (Annual)$1,066,500

Inventory Turnover (Annual)1.74x

Pretax Margin (Annual)-18.38%

Cash / Share (Annual)$0.89

3-Month Return Std Dev54.26%

Gross Margin (5Y Avg)59.32%

Net Income / Employee (TTM)$-165,300

ROE (Last FY)-35.89%

Net Interest Coverage (Annual)-1.99x

EPS Basic Excl Extra (Annual)$-0.47

P/FCF (TTM)62.94x

Receivables Turnover (TTM)3.01x

Total Debt / Equity (Quarterly)0.82x

EPS Incl Extra (TTM)$-0.38

Receivables Turnover (Annual)3.09x

ROI (TTM)-18.37%

P/S Ratio (TTM)2.83x

Pretax Margin (5Y Avg)-31.25%

Revenue / Share (Annual)$2.52

Tangible BV / Share (Annual)$0.16

Forward P/E11.73x

Price vs S&P 500 (52W)-15.81%

Year-to-Date Return-3.11%

5-Day Price Return-5.56%

EPS Normalized (Annual)$-0.47

ROA (5Y Avg)-21.75%

Net Profit Margin (Annual)-18.48%

Month-to-Date Return17.27%

Cash Flow / Share (TTM)$0.07

EBITD / Share (Annual)$-0.16

Operating Margin (Annual)-13.21%

LT Debt / Equity (Annual)0.79x

ROI (5Y Avg)-43.38%

LT Debt / Equity (Quarterly)0.74x

EPS Basic Excl Extra (TTM)$-0.38

P/TBV (Quarterly)22.99x

P/B Ratio (Annual)6.57x

Inventory Turnover (TTM)2.05x

Pretax Margin (TTM)-14.73%

Book Value / Share (Annual)$1.17

Price vs S&P 500 (13W)18.53%

Beta1.09x

P/FCF (Annual)762.94x

Revenue / Share (TTM)$2.37

ROE (TTM)-35.57%

52-Week Low$4.31

vGradeD

gGradeB

mGradeC

vgmGradeC

DERM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	-$0.02	-$0.01	+55.56%(+$0.01)
Q1 2026	May 13, 2026	-$0.09	-$0.08	+8.57%(+$0.01)
Q4 2025	Mar 25, 2026	-$0.06	-$0.04	+30.43%(+$0.02)
Q3 2025	Nov 12, 2025	-$0.04	-$0.09	-140.00%(-$0.05)
Q2 2025	Aug 12, 2025	-$0.10	-$0.16	-52.38%(-$0.06)

DERM Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.10

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
DERMJourney Medical Corporation Common Stock	D	B	C	$7.47
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Journey Medical Corporation Common Stock

Journey Medical Corp commercializes a portfolio of eight FDA-approved prescription drugs for dermatological conditions in the U.S. market. Key products include Qbrexza, Accutane, Amzeeq, and Exelderm, which treat various skin-related medical conditions. The company focuses on dermatological treatments for healthcare providers and patients.